These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 25103663

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Double-hit vitreoretinal lymphoma.
    Or C, Kirker AW, Rasmussen S, Villa D, Gerrie AS, Forooghian F.
    Can J Ophthalmol; 2014 Jun; 49(3):e73-6. PubMed ID: 24862789
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Distinct Profiles of Soluble Cytokine Receptors Between B-Cell Vitreoretinal Lymphoma and Uveitis.
    Takeda A, Yoshikawa H, Fukuhara T, Hikita S, Hijioka K, Otomo T, Arita R, Hisatomi T, Kimura K, Yoshida S, Kawano Y, Sonoda KH, Ishibashi T.
    Invest Ophthalmol Vis Sci; 2015 Nov; 56(12):7516-23. PubMed ID: 26595610
    [Abstract] [Full Text] [Related]

  • 27. MyD-88 L265P mutations are present in some cases of vitreoretinal lymphoma.
    Pulido JS, Salomao DR, Frederick LA, Viswanatha DS.
    Retina; 2015 Apr; 35(4):624-7. PubMed ID: 25768255
    [Abstract] [Full Text] [Related]

  • 28. CLINICAL FEATURES, DIAGNOSTIC SIGNIFICANCE, AND PROGNOSIS OF VITREORETINAL LYMPHOMA IN YOUNG PATIENTS.
    Liu S, Gu J, Zhang T, Ping B, Zhou M, Huang X, Jiang R, Xu G, Chang Q.
    Retina; 2021 Dec 01; 41(12):2596-2604. PubMed ID: 34173362
    [Abstract] [Full Text] [Related]

  • 29. Vitreous microRNA levels as diagnostic biomarkers for vitreoretinal lymphoma.
    Kakkassery V, Schroers R, Coupland SE, Wunderlich MI, Schargus M, Heinz C, Wasmuth S, Heiligenhaus A, Ahle G, Lenoble P, Schlegel U, Schmiegel W, Dick HB, Baraniskin A.
    Blood; 2017 Jun 08; 129(23):3130-3133. PubMed ID: 28389463
    [No Abstract] [Full Text] [Related]

  • 30. Central nervous system involvement of primary cutaneous diffuse large B cell lymphoma-leg type diagnosed according to the WHO 2008 classification.
    Aoki K, Arima H, Tabata S, Matsushita A, Ishikawa T, Takahashi T.
    Ann Hematol; 2012 Dec 08; 91(12):1975-6. PubMed ID: 22592652
    [No Abstract] [Full Text] [Related]

  • 31. Cytokine and molecular analyses of intraocular lymphoma.
    Ohta K, Sano K, Imai H, Kikuchi T.
    Ocul Immunol Inflamm; 2009 Dec 08; 17(3):142-7. PubMed ID: 19585355
    [Abstract] [Full Text] [Related]

  • 32. PREVALENCE OF MYD88 L265P MUTATION IN HISTOLOGICALLY PROVEN, DIFFUSE LARGE B-CELL VITREORETINAL LYMPHOMA.
    Raja H, Salomão DR, Viswanatha DS, Pulido JS.
    Retina; 2016 Mar 08; 36(3):624-8. PubMed ID: 26900675
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Clinical Features and Treatment Outcomes of Vitreoretinal Lymphoma according to Its Association with CNS Lymphoma.
    Cho BJ, Kim DY, Park UC, Lee JY, Yoon YH, Yu HG.
    Ocul Immunol Inflamm; 2018 Mar 08; 26(3):365-371. PubMed ID: 29394118
    [Abstract] [Full Text] [Related]

  • 35. Molecular biomarkers for the diagnosis of primary vitreoretinal lymphoma.
    Wang Y, Shen D, Wang VM, Sen HN, Chan CC.
    Int J Mol Sci; 2011 Mar 08; 12(9):5684-97. PubMed ID: 22016619
    [Abstract] [Full Text] [Related]

  • 36. Immune mediators in vitreous fluids from patients with vitreoretinal B-cell lymphoma.
    Usui Y, Wakabayashi Y, Okunuki Y, Kimura K, Tajima K, Matsuda R, Ueda S, Ma J, Nagai T, Mori H, Kezuka T, Nagao T, Goto H.
    Invest Ophthalmol Vis Sci; 2012 Aug 09; 53(9):5395-402. PubMed ID: 22789925
    [Abstract] [Full Text] [Related]

  • 37. Long-lasting CRs after ibrutinib monotherapy for relapse or refractory primary CNS lymphoma (PCNSL) and primary vitreoretinal lymphoma (PVRL): Long-term results of the iLOC study by the Lymphoma Study Association (LYSA) and the French Oculo-Cerebral Lymphoma (LOC) Network (clinical trial number: NCT02542514).
    Soussain C, Malaise D, Choquet S, Ghesquières H, Houillier C.
    Eur J Cancer; 2023 Aug 09; 189():112909. PubMed ID: 37301714
    [No Abstract] [Full Text] [Related]

  • 38. Consensus Recommendations for the Diagnosis of Vitreoretinal Lymphoma.
    Carbonell D, Mahajan S, Chee SP, Sobolewska B, Agrawal R, Bülow T, Gupta V, Jones NP, Accorinti M, Agarwal M, Batchelor T, Biswas J, Cimino L, tenDam-van Loon NH, de-la-Torre A, Frenkel S, Pe'er J, Kramer M, Miserocchi E, Mochizuki M, Ness T, Rosenbaum JT, Sen HN, Simion M, Sitter H, Vasconcelos-Santos DV, Habot-Wilner Z, Coupland SE, Pulido JS, Smith J, Thorne JE, Zierhut M, Study Group for Vitreoretinal Lymphoma DiagnosticsCentre of Ophthalmology, University of Tuebingen, Tuebingen, Germany..
    Ocul Immunol Inflamm; 2021 Apr 03; 29(3):507-520. PubMed ID: 34009095
    [Abstract] [Full Text] [Related]

  • 39. The molecular hallmarks of primary and secondary vitreoretinal lymphoma.
    Bonzheim I, Sander P, Salmerón-Villalobos J, Süsskind D, Szurman P, Gekeler F, Spitzer MS, Steinhilber J, Kohler E, Büssgen M, Schittenhelm J, Salaverria I, Campo E, Coupland SE, Quintanilla-Martinez L, Fend F.
    Blood Adv; 2022 Mar 08; 6(5):1598-1607. PubMed ID: 34448823
    [Abstract] [Full Text] [Related]

  • 40. Distinct microRNA-155 expression in the vitreous of patients with primary vitreoretinal lymphoma and uveitis.
    Tuo J, Shen D, Yang HH, Chan CC.
    Am J Ophthalmol; 2014 Mar 08; 157(3):728-34. PubMed ID: 24345320
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.